Literature DB >> 33867887

Update on Polycystic Liver Disease.

Stuart C Gordon1.   

Abstract

Entities:  

Year:  2020        PMID： 33867887      PMCID： PMC8040905     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  10 in total

1.  Long-term outcomes and quality of life after surgical or conservative treatment of benign simple liver cysts.

Authors:  Philip de Reuver; Izak van der Walt; Maria Albania; Jaswinder S Samra; Thomas J Hugh
Journal:  Surg Endosc       Date:  2017-06-21       Impact factor: 4.584

Review 2.  Clinical management of polycystic liver disease.

Authors:  René M M van Aerts; Liyanne F M van de Laarschot; Jesus M Banales; Joost P H Drenth
Journal:  J Hepatol       Date:  2017-11-24       Impact factor: 25.083

Review 3.  Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review.

Authors:  Titus F M Wijnands; Alena P M Görtjes; Tom J G Gevers; Sjoerd F M Jenniskens; Leo J Schulze Kool; Andrej Potthoff; Maxime Ronot; Joost P H Drenth
Journal:  AJR Am J Roentgenol       Date:  2016-11-08       Impact factor: 3.959

4.  Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

Authors:  Rene M M van Aerts; Wietske Kievit; Hedwig M A D'Agnolo; Charles J Blijdorp; Niek F Casteleijn; Shosha E I Dekker; Johan W de Fijter; Maatje van Gastel; Tom J Gevers; Liyanne F M van de Laarschot; Marten A Lantinga; Monique Losekoot; Esther Meijer; A Lianne Messchendorp; Myrte K Neijenhuis; Michelle J Pena; Dorien J M Peters; Mahdi Salih; Darius Soonawala; Edwin M Spithoven; Folkert W Visser; Jack F Wetzels; Robert Zietse; Ron T Gansevoort; Joost P H Drenth
Journal:  Gastroenterology       Date:  2019-04-22       Impact factor: 22.682

5.  Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.

Authors:  Loes Van Keimpema; Daan B De Koning; Bart Van Hoek; Aad P Van Den Berg; Martijn G H Van Oijen; Robert A De Man; Frederik Nevens; Joost P H Drenth
Journal:  Liver Int       Date:  2011-01       Impact factor: 5.828

6.  Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset.

Authors:  Cristin Coquillard; Jonathan Berger; Michael Daily; Malay Shah; Xiaonan Mei; Francesc Marti; Roberto Gedaly
Journal:  Liver Int       Date:  2016-01-19       Impact factor: 5.828

7.  Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences.

Authors:  Louise Barbier; Maxime Ronot; Béatrice Aussilhou; François Cauchy; Claire Francoz; Valérie Vilgrain; Olivier Soubrane; Valérie Paradis; Jacques Belghiti
Journal:  Hepatology       Date:  2018-07-11       Impact factor: 17.425

8.  Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.

Authors:  Hedwig M A D'Agnolo; Wietske Kievit; R Bart Takkenberg; Ioana Riaño; Luis Bujanda; Myrte K Neijenhuis; Ellen J L Brunenberg; Ulrich Beuers; Jesus M Banales; Joost P H Drenth
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083

9.  Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.

Authors:  Titus F M Wijnands; Tom J G Gevers; Marten A Lantinga; René H Te Morsche; Leo J Schultze Kool; Joost P H Drenth
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

10.  Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.

Authors:  Myrte K Neijenhuis; Titus F M Wijnands; Wietske Kievit; Maxime Ronot; Tom J G Gevers; Joost P H Drenth
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.